期刊文献+

血流感染粪肠球菌和屎肠球菌的临床分布及耐药研究 被引量:6

Antimicrobial agent susceptibilities and clinical distributions of Enterococcus faecalis and Enterococcus faecium causing bloodstream infection
下载PDF
导出
摘要 回顾性分析上海市某三甲医院血培养阳性标本中粪肠球菌和屎肠球菌的临床分布及对抗菌药物的耐药特征,为临床治疗其所致感染奠定基础。收集上海市某三甲医院2012年2月—2016年9月血流感染患者血液标本中的粪肠球菌和屎肠球菌,采用法国生物梅里埃公司的VITEK 2Compact全自动细菌鉴定和药敏分析系统进行细菌鉴定及药敏测定,研究细菌临床分布特点及对常用抗菌药物的耐药特征。共分离获得30株粪肠球菌和17株屎肠球菌。粪肠球菌样本主要来自泌尿科、消化科和血液科,所占比例分别为13.33%、16.67%和10.00%。粪肠球菌对青霉素、氨苄西林、环丙沙星、左氧氟沙星、四环素和红霉素的耐药率分别为13.33%、10.00%、36.67%、33.33%、66.67%和60.00%。屎肠球菌样本主要来自消化科(29.41%),其对以上抗菌药物的耐药率分别为88.24%、82.35%、88.24%、76.47%、23.53%和70.59%。屎肠球菌对青霉素、氨苄西林、环丙沙星和左氧氟沙星的耐药率显著高于粪肠球菌,而对四环素的耐药率显著低于粪肠球菌。两者均对替加环素、利奈唑胺和万古霉素敏感,但万古霉素对屎肠球菌的最低抑菌浓度显著低于粪肠球菌。结果提示,屎肠球菌对青霉素、氨苄西林、环丙沙星、左氧氟沙星的耐药率高于屎肠球菌,对万古霉素敏感,且其万古霉素最低抑菌浓度低于粪肠球菌。本研究为治疗这两种细菌所致感染的经验性用药提供了数据支持。 The present paper aims to retrospectively analyze the antimicrobial agent susceptibilities and clinical distributions of Enterococcus faecalis(E.faecalis)and E.faecium causing bloodstream infection in a tertiary hospital in Shanghai,and to lay a foundation for the clinical treatment of infections caused by these bacteria.The collected strains of E.faecalis and E.faecium were isolated between February 2012 and September 2016.The bacteria were identified by bioMérieux VITEK antimicrobial susceptibility testing system,and their clinical distribution and drug resistance were analyzed.Thirty E.faecalis and 17 E.faecium strains were obtained.E.faecalis strains were mainly from urology,gastroenterology and hematology departments,accounting for 13.33%,16.67% and 10.00%,respectively.The resistance rates of E.faecalis to penicillin,ampicillin,ciprofloxacin,levofloxacin,tetracycline and erythromycin were13.33%,10.00%,36.67%,33.33%,66.67% and 60.00%,respectively.The resistance rates of E.faecium to these antimicrobial agents were 88.24%,82.35%,88.24%,76.47%,23.53% and 70.59%,respectively.The resistance rates of E.faecium to penicillin,ampicillin,ciprofloxacin and levofloxacin were significantly higher than those of E.faecalis and the resistance rate to tetracycline was significantly lower than that of E.faecalis.Most of the E.faecium(29.41%)samples were from gastroenterology department.Both were sensitive to tigecycline,linezolid and vancomycin. However,the minimum inhibition concentration of vancomycin against E.faecium was significantly lower than that of E.faecalis.This study provided data support for the empirical treatment of infections caused by the two bacteria.
出处 《微生物与感染》 2017年第1期29-34,共6页 Journal of Microbes and Infections
基金 国家青年科学基金(31500154) 上海市科学技术委员会"扬帆计划"(15YF1409500) 上海市卫生和计划生育委员会科研课题(201440289) 上海市第一人民医院"优青前计划"(06N1503012)
关键词 血流感染 粪肠球菌 屎肠球菌 抗菌药物 最低抑菌浓度 Bloodstream infection Enterococcus faecalis Enterococcus faecium Antimicrobial agent Minimum inhibitory concentration
  • 相关文献

参考文献2

  • 1胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
  • 2朱德妹,杨洋,蒋晓飞,王传清,王爱敏,刘瑛,陈峰,倪语星,孙景勇,应春妹,汪雅萍,张泓,孔菁,蒋燕群,汤瑾,周庭银,陈险峰,袁轶群,武楠,汤荣,刘庆忠,杨海慧,卫颖珏,张蓓,黄卫春,王金铎,魏丽,胡必杰,黄声雷,李娜,臧先林,张正银,孙晴,沈燕雅,金文敏,孙杰,沈思娣,康向东,戴俊华,唐群力,冯景,汪瑞忠,房华,唐之俭,王芳,张莉,秦云.2011年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2012,12(6):401-411. 被引量:39

二级参考文献16

  • 1Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 3Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.
  • 4Olsson-Liljequist B, Burman LG. Introducing fosfomycin for surgical prophylaxis-emergence of resistance in aerobic faecal gram-negative bacteria of in patients, but not among strains causing infection after elective colorectal procedures [J ]. Scand J Infect Dis, 1993, 25(6) :725-733.
  • 5Andaker L, Burman LG, Eklund A, et al. Fosfomycin/met- ronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective coloreetal surgery: a randomised double blind multicentre trial in 517 patients[J]. Eur J Surg, 1992, 158(3):181 185.
  • 6Nohr M, Andersen JC, Juul-Jensen KE. Prophylactic single dose fosfomycin and metronidazole compared with neomycin, haeitraein, metronidazole and ampicillin in elective colorectal operations[J]. Acta Chir Seand, 1990, 156(3):223-230.
  • 7Lindhagen J, Hadziomerovic A, Nordlung S, et al. Comparison of systemic prophylaxis with metronidazole-fosfomycin and met- ronidazole-cephalothin in elective colorectal surgery[J]. Acta Chir Scand, 1981, 147(4):277-283.
  • 8Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing[S]. Twenty-First In?formational Supplement v Zul l .M1()O-S21 Vol. 31 No. 1.
  • 9Endimiani A, Patel G. Hujer KM. et al. In vitro activity of fosfomycin against blaKPC-Containing Klebsiella pneumoni?ae isolates, including those nonsusceptible to tigecycline and/ or coiistin] ] ]. Antimicrob Agents Chernother , 201 (), 54( 1) : 526-529.
  • 10Falagas ME, Giannopoulou KP, Kokdakis GN, et al. Fosfo?mycin , use beyond urinary tract and gastrointestinal infec?tions[J]. Clin Infect Dis. 200S, 46(7): 1069-1077.

共引文献553

同被引文献45

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部